This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23; On-demand experience Delivered September 28-30Boston Convention and Exhibition Center

Yasser Kehail
Single Use & Enterprise Business Development Leader at Cytiva, USA


Yasser has over 12 years experience in cell culture manufacturing, development and optimization. He currently supports clients working on different therapeutic modalities such as monoclonal antibodies, plasmid DNA, vaccines and viral vectors. Specifically offering consulting on upstream scale-up strategies and tech transfer. Yasser began his career at Biogen in cell culture manufacturing, and then moved to Upstream PD at Amgen, before joining GE Healthcare Life Sciences and now Cytiva.

Agenda Sessions

  • ROOM 210C: Leveraging lessons from the COVID-19 pandemic to accelerate the development and production of adeno-associated virus (AAV)-based gene therapies